Remove topic drug-pricing
article thumbnail

2024 forecast: Biden admin efforts show there's no pricing relief on the horizon for pharma

Fierce Pharma

As the biopharma world readies for the turn of the calendar, the all-too-familiar topic of drug pricing once again presents an industry-wide overhang. drug prices coming out of Washington, the Biden administration is clearly emboldened on the topic. Based on the series of measures centered on U.S.

Drugs 77
article thumbnail

Over 2,000 drugs in Japan undergo an average price reduction of 9.4% in April

Pharmaceutical Technology

As of 1 April 2023, Japan’s latest ‘off-year’ National Health Insurance (NHI) drug price revisions for FY2023 have now come into effect. While roughly 100 drugs received additional price premiums, the majority of products saw their price reduced as a result of discrepancies between their NHI and market prices.

Drugs 130
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Pharma, patient advocates clash over Inflation Reduction Act

Pharmaceutical Technology

The Inflation Reduction Act, which became US law in August 2022, has invited its fair share of critics and supporters over its drug pricing provisions. While negotiating drug prices is common practice in other major markets, CMS had not previously held the legal authority to do so.

Insulin 130
article thumbnail

Informa Connect’s Life Sciences Pricing & Contracting USA

Drug Channels

Informa Connect’s Life Sciences Pricing & Contracting USA May 21-23, 2024 | New Orleans Drug Channels readers save 10% with code 24DRCH10* Whether your daily focus is on Medicaid, Government Pricing, 340B, Drug Price Transparency, Commercial Contracting or Chargebacks , we have you covered!

article thumbnail

EXCLUSIVE: The 340B Program Reached $54 Billion in 2022—Up 22% vs. 2021 (rerun)

Drug Channels

This week, I’m rerunning some popular posts while I prepare for today’s Drug Channels Outlook 2024 live video webinar. My topic #9 for 2024: The Battle Over 340B Gets Even Messier. Drug Channels has just obtained new details on the size of the 340B Drug Pricing Program. d/b/a Drug Channels Institute.

article thumbnail

Informa Connect’s Drug Pricing Transparency Congress

Drug Channels

Experts from across the industry will discuss how current and future drug pricing transparency regulations will impact commercialization, reimbursement, pricing and compliance practices. Drug Channels readers will save 10% off when they use code 23DRCH10 and register prior to March 31, 2023.*

Drugs 84
article thumbnail

Listen: Whither PhRMA, Alzheimer’s treatment data revealed, and the first fecal microbiome drug approval

STAT News

The first FDA-approved fecal microbiome drug. We cover all these topics and more on this week’s episode of “The Readout LOUD,” STAT’s biotech podcast. We also discuss the FDA approval of a microbiome drug for the treatment of a bowel disorder and the potential for a big acquisition of Horizon Therapeutics.